By Svea Herbst-Bayliss NEW YORK (Reuters) – Contract drugmaker Catalent, which is being pushed to make changes to its board by Elliott Investment Management, had at least two other activist …
Topic:
catalent
-
-
By Maggie Fick LONDON (Reuters) – Activist investor Elliott Investment has taken a stake in contract drugmaker Catalent, a source familiar with the matter told Reuters on Thursday. The Wall …